Annogen
PrivateCompany Overview
Annogen operates in Healthcare & Life Sciences and is based in Amsterdam. It was founded in 2017.
Annogen is a biotechnology company that provides gene expression engineering services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Annogen Comparables
Compare Annogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chromatin Bioscience | 84% | |
| SynGenSys | 84% | |
| Bayer AG | 74% |
For institutional investors. Book with your work email.
Annogen Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 284% MoM, from 531 to 2K.
- Feb 16, 2026
Grew 50% QoQ from 6 to 9 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 14, 2026
On Oct 15th '26 in the Netherlands, Annogen BV and Genewity announce a research collaboration to identify and validate promoters for stem cell-based gene therapies for children with severe genetic diseases.
For institutional investors. Book with your work email.
Annogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Annogen's valuation, stock price, and market status.
Is Annogen a public or private company?
Annogen is a private company.
What is the current stock price of Annogen?
Annogen is a private company, so its shares have no public market price. Caplight tracks Annogen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Annogen worth (valuation)?
Valuation information for Annogen is not publicly available.
Can I buy Annogen stock?
Annogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Annogen's last funding round?
Funding round information for Annogen is not publicly available.
Who are the main investors in Annogen?
Investor information for Annogen is not publicly disclosed.
Will Annogen IPO soon?
No public IPO plans have been announced for Annogen.
How can I track Annogen secondary market activity?
Caplight tracks bids, offers, and trades in Annogen's shares on secondary markets.